US7611521078
US7611521078
ResMed Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 32.35B EUR | 28.11B EUR | 32.56B EUR | 35.09B EUR |
Enterprise Value | 32.06B EUR | 27.47B EUR | 31.74B EUR | 34.52B EUR |
Valuation Multiples | ||||
Trailing P/E | 22.06x | 18.45x | 21.43x | 31.3x |
Forward P/E | 17.39x | -- | -- | -- |
Price to Sales | 5.72x | 4.97x | 5.88x | 8.54x |
Price to Book | 5.04x | 4.27x | 5.02x | 5.55x |
EV/Revenue | 5.67x | 4.86x | 5.73x | 8.41x |
EV/EBITDA | 15.3x | 12.63x | 14.41x | 21.12x |
Price to FCF (P/FCF) | 34.45x | 17.26x | 18.75x | 28.72x |
EV/FCF | 34.14x | 16.86x | 18.28x | 28.25x |
FCF Yield | 2.9% | 5.79% | 5.33% | 3.48% |